Baseline predictors of persistence to first disease-modifying treatment in multiple sclerosis
Wissenschaftlicher Artikel
Faculties
Medizinische FakultätInstitutions
UKU. Klinik für NeurologiePublished in
Acta Neurologica Scandinavica ; 136 (2017), 2. - S. 116-121. - ISSN 0001-6314. - eISSN 1600-0404
Link to publication
https://dx.doi.org/10.1111/ane.12705Funding information
Bayer Vital GmbH, Leverkusen, Germany